Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Translational Research : the Journal of Laboratory and Clinical Medicine|August 31, 2010
Pluripotent stem cell-derived natural killer cells for cancer therapyDavid A Knorr, Dan S Kaufman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Immunotherapy and Hyperprogression: Unwanted Outcomes, Unclear MechanismDavid A Knorr, Jeffrey V Ravetch
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2018
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunityDavid A Knorr, Rony Dahan, Jeffrey V Ravetch
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2013
Hematopoietic and nature killer cell development from human pluripotent stem cellsZhenya Ni, David A Knorr, Dan S Kaufman
Cancer Cell|November 17, 2023
The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactionsJuan C Osorio, Patrick Smith, David A Knorr, et al.
Seminars in Immunology|March 13, 2014
Clinical utility of natural killer cells in cancer therapy and transplantationDavid A Knorr, Veronika Bachanova, Michael R Verneris, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2023
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactionsJuan C Osorio, Patrick Smith, David A Knorr, et al.
Stem Cells and Development|February 21, 2013
Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapyDavid A Knorr, Allison Bock, Renier J Brentjens, et al.
Science Translational Medicine|May 20, 2021
Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancerChristopher S Garris, Jeffrey L Wong, Jeffrey V Ravetch, et al.
Stem Cells (Dayton, Ohio)|December 6, 2013
Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivoZhenya Ni, David A Knorr, Laura Bendzick, et al.
Pageof 4